Author steps in to clarify vague tuberculosis retraction

You’ve got to love when an author is willing to detail the specifics of an unhelpful retraction notice.

This May, a paper came out in Journal of Thoracic Diseases about drug-resistant tuberculosis. It was retracted in June, for “some misconduct in the manuscript.”

Here’s the notice:

The article “Application status of MALDI-TOF mass spectrometry in the identification and drug resistance of Mycobacterium tuberculosis” (doi: 10.3978/j.issn.2072-1439.2014.02.19) that appeared on page 512-516 of the May 2014 issue of the Journal of Thoracic Disease needs to be withdrawn due to some misconduct in the manuscript. We are sorry for the inconvenience caused.

Since that’s pretty vague and unhelpful, we reached out to corresponding author Jiayun Liu, who gave us a thorough rundown:

Continue reading Author steps in to clarify vague tuberculosis retraction

Why was that lung cancer paper retracted? The “authors’ reason,” of course

jthordisTwo researchers who wrote a review article on the genetics of lung cancer have retracted the paper. But why evidently is for them to know and us to find out.

The article, “Epigenetic aberrant methylation of tumor suppressor genes in small cell lung cancer,” was published in the August 2013 issue of the Journal of Thoracic Disease by authors from Shandong University in China.

According to the retraction notice: Continue reading Why was that lung cancer paper retracted? The “authors’ reason,” of course